Who are Methyl B12's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Cyanocobalamin Co 57, Mecobalamin IM injection, Vitamin B12, Vitamin B12 (Cyanocobalamin), i.m. injection of vitamin B12, Methylcobalamin (methylB12).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/methyl-b12.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Methyl B12 — Competitive Intelligence Brief

Methyl B12 (Methyl B12) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B12 supplement. Area: Hematology / Neurology.

marketed Vitamin B12 supplement Methionine synthase Hematology / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Methyl B12 (Methyl B12) — University of California, San Francisco. Methylcobalamin (Methyl B12) acts as a coenzyme in one-carbon transfer reactions and methionine synthesis, supporting DNA synthesis, myelin formation, and neurological function.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Methyl B12 TARGET	Methyl B12	University of California, San Francisco	marketed	Vitamin B12 supplement	Methionine synthase
Cyanocobalamin Co 57	cyanocobalamin (57Co)	Mallinckrodt	marketed	Radioactive Diagnostic Agent	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial, Methionine synthase, Methionine synthase reductase	1968-01-01
Mecobalamin IM injection	Mecobalamin IM injection	Eisai Co., Ltd.	marketed	Vitamin B12 analog	Methionine synthase; B12-dependent enzymes
Vitamin B12	Vitamin B12	Acrotech Biopharma Inc.	marketed	Vitamin / Essential nutrient	Methionine synthase, methylmalonyl-CoA mutase
Vitamin B12 (Cyanocobalamin)	Vitamin B12 (Cyanocobalamin)	University of Aarhus	marketed	Vitamin / Essential nutrient	Methionine synthase; methylmalonyl-CoA mutase
i.m. injection of vitamin B12	i.m. injection of vitamin B12	University Hospital, Basel, Switzerland	marketed	Vitamin supplement / Essential nutrient	Methionine synthase, methylmalonyl-CoA mutase
Methylcobalamin (methylB12)	Methylcobalamin (methylB12)	Arkansas Children's Hospital Research Institute	marketed	Vitamin B12 supplement / Cobalamin	Methionine synthase; methylmalonyl-CoA mutase cofactor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B12 supplement class)

University of California, San Francisco · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methyl B12 — Competitive Intelligence Brief. https://druglandscape.com/ci/methyl-b12. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab